🇺🇸 FDA
Patent

US 11623918

Compounds for the treatment of acute and chronic kidney disease

granted A61PA61P13/12

Quick answer

US patent 11623918 (Compounds for the treatment of acute and chronic kidney disease) held by United States Government as represented by the Department of Veterans Affairs expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P13/12